New Nanofiber-Based Wound Dressings Can Prevent Surgical Site Infections
Posted on 28 Feb 2022
Researchers have uncovered a possible new preventative technique to prevent dangerous and costly surgical site infections, the type of infection most commonly associated with health care procedures.
The new preventative technique developed by scientists at Oregon State University (Corvallis, OR, USA) and the University of Nebraska Medical Center (Omaha, NE, USA) involves adding an enzyme inhibitor to nanofiber-based wound dressings loaded with vitamin D, resulting in cells better producing an antimicrobial peptide. Vitamin D, fat soluble and present in very few foods – including the flesh of fatty fish, beef liver, cheese and egg yolks – promotes calcium absorption in the gut and is needed for bone health. Manufactured by the body when triggered by sunlight, it’s also important for cell growth, neuromuscular function and inflammation reduction.
In this latest study, the researchers tested wound dressings containing both the bioactive form of vitamin D – 1,25-dihydroxyvitamin D3, or 1,25(OH)2D3 – and another compound known as VID400 developed at the University of Nebraska Medical Center. The team had earlier looked at bioactive vitamin D’s role in promoting the body’s production of the antimicrobial peptide LL-37, linked to a gene, CAMP, that’s present in humans and other primates. Other mammals, including mice, have a similar gene, Camp, but vitamin D does not trigger it to set in motion LL-37 production.
To study how vitamin D and the CAMP gene work together to help thwart infection, the research team developed a line of mice that carry the CAMP gene but not Camp. They bred mice engineered to carry human CAMP to mice with their Camp gene knocked out, resulting in mice with an antimicrobial peptide gene regulated by the bioactive form of vitamin D. That research showed that the mice with the human CAMP gene displayed enhanced resistance to gut infections, and that staph infections on their skin could be successfully treated with the bioactive form of the vitamin. Like the previous work, the latest study used human skin tissue, collected from plastic surgery patients, in culture as well as the CAMP mouse model. It builds on the earlier findings by showing that VID400 prevents the vitamin D from degrading, meaning it can do a better job of activating the CAMP gene, which means better infection protection.
“Because these wound dressings work by enhancing innate immune responses rather than by containing conventional, single-target antimicrobial compounds, they are less likely to contribute to drug resistance,” said OSU researcher Adrian Gombart. “This research clearly shows the potential of the nanofiber dressings loaded with both bioactive vitamin D and VID400 to help prevent surgical site infections by inducing antimicrobial peptide expression better than either compound alone.”
Related Links:
Oregon State University
University of Nebraska Medical Center
